Consistently, it was reported that serum HMGB1 levels were lowered in women with PCOS after therapy with the insulin sensitizer metformin [23], or with the putative mediator of insulin signaling myo-inositol, combined with alpha-lipoic acid [24]. Here, HMGB1 is linked to polycystic ovary syndrome.